Defecetive Drugs: adrugrecall.com

NEWSLETTER

Sign up for our newsletter
to receive breaking news about drugs to watch

Potential liver problems associated to Accolate cause shares to slip

-April 19, 2004

After a letter said an analysis of safety databases indicate some Accolate patients experienced liver problems, including hepatitis, shares in Accolate's AstraZeneca Plc slipped. While Accolate labels do warn of potential liver problems already, it is important for all consumers to be aware of drug risks as well as potential benefits. For more information on Accolate, please contact us.

view more of this month's articles

Contact Us

• Home
• Bookmark Site
• Legal Disclaimer
• Site Map